FDA Deputy Commissioner Returns to CRN Conference

August 12, 2010

FDA principal deputy commissioner Joshua Sharfstein, MD, is slated to return as a keynote speaker at The Conference, the Council for Responsible Nutrition's annual symposium for the dietary supplement industry.

FDA (Rockville, MD) principal deputy commissioner Joshua Sharfstein, MD, is slated to return as a keynote speaker at The Conference, the Council for Responsible Nutrition's (CRN; Washington, DC) annual symposium for the dietary supplement industry. The Conference will take place September 29 to October 2 at the Hyatt Regency Lost Pines Resort & Spa outside of Austin, Texas.

Sharfstein will make the opening address to attendees, providing an update on FDA's dietary supplement-related regulatory activities. Sharfstein will discuss the impact of the current regulatory landscape of the recently fully implemented dietary supplement good manufacturing practices (GMPs), as well as the adverse-event reporting (AER) law.

Additionally, he will update conference attendees on critical supplement industry issues, such as the long-awaited new dietary ingredient (NDI) notification guidance.

Registration for The Conference is open to members and non-members of CRN. For more information, click here.